<?xml version="1.0" encoding="UTF-8"?>
<p>It is highly probable that one of the aforementioned therapeutic agents will become useful in coronavirus infection therapy. According to research reports, another less common approach to improve the activity of the immune system also seems promising. Colony-stimulating factors like GM-CSF might exacerbate reaction to the infection [
 <xref rid="B123-jcm-09-01917" ref-type="bibr">123</xref>] and accelerate the elimination of viruses [
 <xref rid="B124-jcm-09-01917" ref-type="bibr">124</xref>]. Nevertheless, it is important to remember that this approach does not seem to be appropriate in the patient in critical condition. Its usefulness in the first day of therapy of nonsevere patients is still hard to predict due to a lack of clinical data verifying the effectiveness of improving viral clearance and treatment outcomes [
 <xref rid="B124-jcm-09-01917" ref-type="bibr">124</xref>]. 
</p>
